PuSH - Publication Server of Helmholtz Zentrum München: Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Schneidt, V.* ; Ilecka, M.* ; Dreger, P.* ; van Zyl, D.G.* ; Fink, S.* ; Mautner, J. ; Delecluse, H.J.*

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo.

Leukemia 33, 88-98 (2018)

Publ. Version/Full Text

Postprint

Research data

DOI

	Open Access Green

Abstract
Metrics
Extra information

Chronic lymphocytic leukemia (CLL) is the most frequent B cell malignancy in Caucasian adults. The therapeutic armamentarium against this incurable disease has recently seen a tremendous expansion with the introduction of specific pathway inhibitors and innovative immunotherapy. However, none of these approaches is curative and devoid of side effects. We have used B-cell-specific antibodies conjugated with antigens (AgAbs) of the Epstein-Barr virus (EBV) to efficiently expand memory CD4(+) cytotoxic T lymphocytes (CTLs) that recognized viral epitopes in 12 treatment-naive patients with CLL. The AgAbs carried fragments from the EBNA3C EBV protein that is recognized by the large majority of the population. All CLL cells pulsed with EBNA3C-AgAbs elicited EBV-specific T cell responses, although the intensity varied across the patient collective. Interestingly, a large proportion of the EBV-specific CD4(+) T cells expressed granzyme B (GrB), perforin, and CD107a, and killed CLL cells loaded with EBV antigens with high efficiency in the large majority of patients. The encouraging results from this preclinical ex vivo study suggest that AgAbs have the potential to redirect immune responses toward CLL cells in a high percentage of patients in vivo and warrant the inception of clinical trials.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Chronic Lymphocytic-leukemia; Epstein-barr-virus; B-cells; Presenting Cells; Dysfunction; Receptor; Protein; Transplantation; Peptides; Epitopes

ISSN (print) / ISBN 0887-6924

e-ISSN 1476-5551

Journal Leukemia

Quellenangaben Volume: 33, Issue: 1, Pages: 88-98

Publisher Nature Publishing Group

Publishing Place Macmillan Building, 4 Crinan St, London N1 9xw, England

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Research Unit Gene Vector (AGV)